TSX:MUX

McEwen Inc. Announces  Voting Results of the 2026 Annual Meeting of Shareholders

MUX annual meeting approves director slate, auditor, and share issuance

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>&lt;link type=&quot;text/css&quot; rel=&quot;stylesheet&quot; href=&quot;https://www.globenewswire.com/styles/gnw_nitf.css&quot;&gt;&lt;/li...</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>McEwen Inc. reported results from its June 4, 2026 annual meeting, including the election of 11 directors, ratification of EY as auditor for 2026, and approval of a share issuance to founder Rob McEwen under a Canadian Gold Corp. arrangement. The approved issuance signals ongoing capital actions to fund growth, notably the El Gallo revival and the Los Azules copper project, while Paragon Labs’ 27.3% stake and PhotonAssay technology may bolster ESG and efficiency initiatives. The mix of governance continuity and strategic financing could influence MUX’s capital structure and per-share metrics in the near term.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>MUX annual meeting held June 4, 2026; 11 directors elected; EY auditor ratified.</li><li>Share issuance to Rob McEwen approved under arrangement with Canadian Gold Corp.</li><li>Voting: 34,079,421 shares voted; 57.32% turnout of 59,452,799 eligible.</li><li>Growth focus: El Gallo reactivation and Los Azules copper project; US$457m implied value.</li><li>Paragon Advanced Labs stake; PhotonAssay tech could become industry standard.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>McEwen Inc. (MUX)</strong>: Primary issuer; annual meeting approvals; potential near-term dilution.</li><li><strong>Ernst &amp; Young LLP (EY)</strong>: Auditor appointment ratified for fiscal 2026; governance signal.</li><li><strong>Canadian Gold Corp. (CGC)</strong>: Counterparty in share issuance arrangement; potential price impact if issuance size disclosed.</li><li><strong>Paragon Advanced Labs Inc. (Unknown)</strong>: 27.3% stake acquired; PhotonAssay technology could shift industry standard.</li><li><strong>McEwen Copper / Los Azules (N/A)</strong>: Long-life copper project; US$457m implied value; ESG targets including carbon neutrality by 2038.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. The article covers governance, capital actions, and strategic asset updates, all of which can influence MUX’s valuation, dilution considerations, and growth trajectory.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Share issuance to Rob McEwen approved; dilution risk could affect near-term equity value.</li><li>El Gallo reactivation and Los Azules project underpin near-term growth potential.</li><li>Auditor confirmation (EY) supports governance stability and financial oversight.</li><li>Paragon Advanced Labs stake and PhotonAssay tech may improve efficiency and ESG profile.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date of meeting: June 4, 2026.</li><li>Shares voted: 34,079,421; turnout 57.32% of 59,452,799 outstanding.</li><li>Directors elected: 11.</li><li>Auditor: Ernst &amp; Young LLP ratified for FY2026.</li><li>Share issuance to Rob McEwen approved under Arrangement with Canadian Gold Corp.</li><li>Los Azules implied value: US$457 million.</li><li>Paragon Advanced Labs Inc. stake: 27.3%.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>MUX could trend higher in 6–12 months as growth catalysts advance and dilution remains manageable.</p>
  </section>
</section>


<article>
  <section>
    <h2>McEwen Inc. Announces 2026 Annual Meeting Voting Results</h2>
    <p>The governance action news from McEwen Inc. TSX:MUX and TSX:MUX coverage confirms that shareholders approved key corporate actions at the MUX Annual Meeting of Shareholders held on June 4, 2026. This includes the election of directors, ratification of the independent auditor for the fiscal year ending December 31, 2026, and the issuance of common stock to Robert R. McEwen. The announcements highlight ongoing governance, alignment with shareholder interests, and capital actions relevant to investors following the 2026 meeting. </p>
  </section>

  <section aria-labelledby="voting-overview">
    <h2 id="voting-overview">Voting Overview and Actions Approved</h2>
    <ul>
      <li><strong>Shares Voted:</strong> <strong>34,079,421</strong>, representing <strong>57.32%</strong> of <strong>59,452,799</strong> outstanding shares entitled to vote</li>
      <li><strong>Board Elected:</strong> 11 Directors</li>
      <li><strong>Auditor Appointment:</strong> Ernst & Young LLP appointment ratified for FY2026</li>
      <li><strong>Share Issuance to Mr. McEwen:</strong> Approved</li>
    </ul>
  </section>

  <section aria-labelledby="detailed-results">
    <h2 id="detailed-results">Detailed Voting Results</h2>
    <p>Percentages are calculated from votes For and Against/Withheld, as applicable; abstentions, broker non-votes and uncast shares are excluded.</p>

    <p>Election Results for the Directors Nominated at the Meeting:</p>
    <table border="1" cellpadding="6" cellspacing="0" width="100%">
      <thead>
        <tr>
          <th>Director Nominee</th>
          <th>Votes For</th>
          <th>% For</th>
          <th>Votes Withheld</th>
          <th>% Withheld</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Robert R. McEwen</td>
          <td>25,683,647</td>
          <td>96.96%</td>
          <td>806,486</td>
          <td>3.04%</td>
        </tr>
        <tr>
          <td>Dalia Asterbadi</td>
          <td>26,241,182</td>
          <td>99.06%</td>
          <td>248,951</td>
          <td>0.94%</td>
        </tr>
        <tr>
          <td>Ian J. Ball</td>
          <td>25,415,060</td>
          <td>95.94%</td>
          <td>1,075,073</td>
          <td>4.06%</td>
        </tr>
        <tr>
          <td>Richard W. Brissenden</td>
          <td>25,650,004</td>
          <td>96.83%</td>
          <td>840,129</td>
          <td>3.17%</td>
        </tr>
        <tr>
          <td>Alfred Colas</td>
          <td>26,259,077</td>
          <td>99.13%</td>
          <td>231,056</td>
          <td>0.87%</td>
        </tr>
        <tr>
          <td>Nicolas Darveau-Garneau</td>
          <td>26,256,818</td>
          <td>99.12%</td>
          <td>233,315</td>
          <td>0.88%</td>
        </tr>
        <tr>
          <td>Steve Kaszas</td>
          <td>26,186,071</td>
          <td>98.85%</td>
          <td>304,062</td>
          <td>1.15%</td>
        </tr>
      </tbody>
    </table>
  </section>

  <section aria-labelledby="context">
    <h2 id="context">Context and Implications for Investors</h2>
    <p>The voting results demonstrate strong shareholder support for management’s governance framework and the proposed capital actions for the 2026 fiscal year. The unanimous or near-unanimous approval of key director nominees aligns with oversight expectations from investors tracking TSX:MUX performance and governance standards. This release also underscores the importance of the independent auditor confirmation and the planned issuance of common stock to a notable Company executive.</p>
  </section>
</article>

McEwen Inc. reported results from its June 4, 2026 annual meeting, including the election of 11 directors, ratification of EY as auditor for 2026, and approval of a share issuance to founder Rob McEwen under a Canadian Gold Corp. arrangement. The approved issuance signals ongoing capital actions to fund growth, notably the El Gallo revival and the Los Azules copper project, while Paragon Labs’ 27.3% stake and PhotonAssay technology may bolster ESG and efficiency initiatives. The mix of governance continuity and strategic financing could influence MUX’s capital structure and per-share metrics in the near term.

McEwen Inc. Announces Voting Results of the 2026 Annual Meeting of Shareholders

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News